ICD10 code of Batten Disease and ICD9 code

Batten disease, also known as Neuronal Ceroid Lipofuscinosis (NCL), is classified under ICD-10 code E75.4 (Neuronal ceroid lipofuscinosis) and ICD-9 code 330.1 (Cerebral lipidoses). These codes are used globally for clinical coding, insurance billing, and medical record documentation for the various genetic forms of Batten disease.

What exactly is Batten disease?

Batten disease is the common name for a broad group of rare, fatal, hereditary disorders of the nervous system known as Neuronal Ceroid Lipofuscinoses (NCLs). These conditions are characterized by the accumulation of lipopigments (lipofuscin) within the body's tissues, which progressively damages neurons in the brain and eyes. Because Batten disease is a group of disorders, the age of onset and the rate of progression can vary significantly depending on the specific genetic mutation involved, ranging from infantile to adult-onset forms.

How are the ICD codes for Batten disease applied?

Medical coding is essential for tracking the clinical course of Batten disease. The ICD-10 code E75.4 is the primary diagnostic classification for all types of NCL. In clinical practice, physicians may also use additional ICD-10 codes to specify associated symptoms, such as G40.3 (Generalized idiopathic epilepsy and epileptic syndromes) or H54 (Blindness and low vision), as these are common manifestations of the disease. Accurate coding ensures that patients receive appropriate medical resources and helps researchers track the prevalence of Batten disease within global health databases.

Is Batten disease hereditary?

Yes, Batten disease is an autosomal recessive genetic disorder. This means that an individual must inherit two copies of a mutated gene—one from each parent—to develop the condition. When both parents are carriers, there is a 25% chance with each pregnancy that the child will be affected by Batten disease. Genetic counselors play a vital role for families navigating a diagnosis, helping them understand the specific mutation involved and the implications for siblings and future family planning.

What are the primary clinical features of Batten disease?

While the progression of Batten disease varies by subtype, common clinical indicators typically include a combination of the following:

• Progressive loss of vision or retinal degeneration.


• Seizures (often the first neurological sign).


• Cognitive decline and loss of previously acquired skills (developmental regression).


• Motor disturbances, including ataxia (loss of coordination) and spasticity.


• Behavioral changes, such as anxiety, irritability, or sleep disturbances.

Next steps

• Consult with a pediatric neurologist or a metabolic specialist to confirm the specific genetic subtype of Batten disease.


• Request a referral to a genetic counselor to discuss family testing and recurrence risks.


• Join specialized patient advocacy groups such as the Batten Disease Support and Research Association (BDSRA) for up-to-date information on clinical trials and supportive care.


• Connect with the community at DiseaseMaps.org to share experiences with others living with rare neurodegenerative conditions.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Batten disease.


• Orphanet: Neuronal ceroid lipofuscinosis (ORPHA:638).


• OMIM (Online Mendelian Inheritance in Man): Entry #204200 (Ceroid Lipofuscinosis, Neuronal, 1).


• Batten Disease Support and Research Association (BDSRA): Understanding NCLs.